Tivic Health Systems, Inc. TIVC 深 沪
交易中 05-18 10:55:06 美东时间
1.40
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 1.40
- 总市值 402.91万
- 52周最高 5.60
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.7217
- 委 比 0.00%
- 总股本 287.79万
- 历史最高 11050.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.7217
- 每 手 1
- 风险率 1.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening
Tivic Health Systems Inc. shares rise 24.10% after hours after announcing a full rebrand to Valion Bio and a strategic pivot toward Entolimod-based immunotherapy development.
04-24 16:17
美股夜盘 | MaxLinear, Inc.涨32.76%，World Kinect Corporation涨25.32%
MaxLinear, Inc.涨32.76%；World Kinect Corporation涨25.32%；英特尔涨20.49%
04-24 09:01
美股夜盘 | MaxLinear, Inc.涨32.38%，Tivic Health Systems, Inc.涨26.79%
EUDA Health Holdings Limited涨-12.57%；Medicus Pharma Ltd涨-9.18%；Amesite Inc.涨-9.03%
04-24 08:05
美股夜盘 | Tivic Health Systems, Inc.涨35.71%，最新股价1.52美元
Tivic Health Systems, Inc.涨35.71%，报1.52美元
04-24 08:00
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers iTonic Holdings (NASDAQ:ITOC) shares increased by 49.5% to $0.44 during...
04-24 05:05
'Tivic Health Aims To Advance Immunotherapy Research Programs' - USA Today
https://www.usatoday.com/story/special/contributor-content/2026/03/25/biotech-company-tivic-health-aims-to-advance-immunotherapy-research-programs/89318926007/
03-26 04:44
Tivic Health Systems Appoints Michael K. Handley CEO, Effective Immediately, Succeeding Jennifer Ernst
Tivic Health Systems, Inc. (Nasdaq:TIVC) ("Tivic" or the "Company"), a late-stage immunotherapeutics company, today announced that its Board of Directors has appointed Michael K. Handley as Chief Executive Officer of
03-04 21:37
Tivic Says Second, Follow-Up Meeting With BARDA Scheduled For March 10, To Continue Discussions On Clinical Data And Potential For Funding And Stockpiling Entolimod For ARS
Initial presentation on January 26, 2026 showcased Entolimod's potential to mitigate and prevent both gastrointestinal and hematopoietic injury from ionizing radiation exposure.FREMONT, CA / ACCESS Newswire / February
02-18 22:18
Tivic Health Systems Presents Data On Toll-like Receptor 5 Agonist Entolimod
Tivic Health® Systems, Inc. (Nasdaq:TIVC), a late-stage immunotherapeutics company, today announced that it delivered an invited presentation at a TechWatch meeting with the Biomedical Advanced Research and
01-28 21:33
